# The ATLANTA First in Man Study of the Catania Stent

> **NCT00799032** · PHASE1 · COMPLETED · sponsor: **CeloNova BioSciences, Inc.** · enrollment: 55 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** PCI

## Key facts

- **NCT ID:** NCT00799032
- **Lead sponsor:** CeloNova BioSciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-05
- **Primary completion:** 2007-08
- **Final completion:** 2008-08
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799032, "The ATLANTA First in Man Study of the Catania Stent". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00799032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*